WallStSmart
CGEN

Compugen

NASDAQ: CGEN · HEALTHCARE · BIOTECHNOLOGY

$2.66
+2.31% today

Updated 2026-04-30

Market cap
$268.77M
P/E ratio
7.45
P/S ratio
3.69x
EPS (TTM)
$0.38
Dividend yield
52W range
$1 – $3
Volume
0.4M

Compugen (CGEN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-9.93M$-8.41M$-10.01M$-7.45M$-4.28M$-9.25M$-10.85M$-6.44M$-11.15M$-25.61M$-19.82M$-30.66M$-13.29M$-27.89M$-28.32M$-23.22M$-33.92M$-35.89M$49.60M$31.63M
Capital expenditures$161000.00$205000.00$120000.00$48000.00$46000.00$96000.00$1.00M$328000.00$1.90M$3.12M$2.60M$385000.00$158000.00$155000.00$166000.00$292000.00$487000.00$172000.00$118000.00$306000.00
Depreciation
Stock-based comp$-47000.00$1.80M$1.53M$2.34M$3.40M$2.47M$3.54M$3.63M$3.77M$3.08M$2.63M$2.17M$2.41M$2.77M$4.28M$4.33M$3.55M$3.02M$1.88M
Free cash flow$-10.09M$-8.61M$-10.13M$-7.50M$-4.33M$-9.35M$-11.85M$-6.77M$-13.04M$-28.73M$-22.42M$-31.04M$-13.45M$-28.04M$-28.49M$-23.51M$-34.41M$-36.06M$49.49M$31.33M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash